Zubsolv Tablet, Orally Disintegrating
Product Images NDC 54123-986

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Zubsolv (NDC 54123-986). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orexo Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Buprenorphine HCl Is (2s)-2-[17-(cyclopropylmethyl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethano-14α-morphinan-7α-yl]-3,3-dimethylbutan-2-ol Hydrochloride. (Zubsolv Sublingual Tablets 01)

Chemical structure of buprenorphine hydrochloride, the active ingredient in Zubsolv tablets, depicted as a molecular diagram with labeled functional groups and the HCl component.*

FDA Label Image

The Following Chemical Structure For Naloxone HCl Dihydrate Is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride Dihydrate. (Zubsolv Sublingual Tablets 02)

Chemical structure diagram of buprenorphine hydrochloride with the formula notation HCl · 2H2O, depicting the molecular framework and key functional groups of the active ingredient in Zubsolv tablets.*

FDA Label Image

Pull Apart 1 Of The Blister Units From The Blister Pack By Tearing Along The Dotted Lines (perforations) Until It Is Fully Separated (see Figure A). (Zubsolv Sublingual Tablets 03)

An instructional diagram showing a hand peeling open a blister package to access a tablet. The image illustrates the motion of lifting a foil backing from the blister containing the medication.*

FDA Label Image

When The Blister Unit Is Fully Separated, Fold The Single Unit Down At Dotted Line Toward The Blister (see Figure B). (Zubsolv Sublingual Tablets 04)

An instructional illustration showing two hands preparing a tablet for administration. One hand holds a tablet, and the fingers of the other hand are positioned to peel or separate a section, indicated by an arrow pointing downward. The image is labeled 'Figure B' and likely demonstrates how to handle or administer the orally disintegrating tablet.*

FDA Label Image

Slowly Tear Down At Notch To Open The Blister Unit (see Figure C). (Zubsolv Sublingual Tablets 05)

Instructional illustration showing hands opening a child-resistant cap on a small bottle or container by pushing down and turning, indicated by a downward arrow. The image appears to guide safe opening of medication packaging.*

FDA Label Image

As Soon As You Remove Your Prescribed Dose Of Zubsolv From The Blister Pack Place The Tablet Under Your Tongue (see Figures D, E, And F). If More Than 1 Tablet Is Required, Place The Tablets In Different Places Under Your Tongue At The Same Time. (Zubsolv Sublingual Tablets 06)

An instructional illustration labeled "Figure D" showing a person inserting a sublingual orally disintegrating tablet under their tongue with a finger. The image demonstrates the proper method to take Zubsolv sublingual tablets.*

FDA Label Image

Principal Display Panelndc 54123-907-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets0.7 mg/0.18 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reach Of Children. Buprenorphine Can Cause Severe, Possibly Fatal, Respiratory Depression In Children. Children Who Accidentally Take Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guide For Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 07)

An instructional black-and-white illustration showing a person's open mouth with a tablet placed on the tongue, demonstrating the sublingual administration of the medication Zubsolv tablets.*

FDA Label Image

Principal Display Panelndc 54123-914-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets1.4 mg/0.36 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reach Of Children. Buprenorphine Can Cause Severe, Possibly Fatal, Respiratory Depression In Children. Children Who Accidentally Take Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guide For Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 08)

Illustration showing a person placing an orally disintegrating tablet on their tongue, demonstrating the sublingual route of administration for Zubsolv buprenorphine hydrochloride and naloxone hydrochloride tablets.*

FDA Label Image

Principal Display Panelndc 54123-929-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets2.9 mg/0.71 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reachof Children. Buprenorphine Can Cause Severe, Possibly Fatal,respiratory Depression In Children. Children Who Accidentallytake Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guidefor Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 09)

Zubsolv 0.7 mg/0.18 mg sublingual tablets packaging label for 30 orally disintegrating tablets (10 tablets x 3 cards) in menthol flavor. The label shows the brand name, generic names buprenorphine hydrochloride and naloxone hydrochloride, strength, usage instructions, safety warnings, manufacturer Orexo US, Inc., and storage information. NDC 54123-907-30 is displayed.*

FDA Label Image

Principal Display Panelndc 54123-957-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets5.7 mg/1.4 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reach Of Children. Buprenorphine Can Cause Severe, Possibly Fatal, Respiratory Depression In Children. Children Who Accidentally Take Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guide For Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 0a)

Packaging label for Zubsolv 1.4 mg/0.36 mg sublingual tablets, an orally disintegrating tablet with menthol flavor. The label displays the proprietary name Zubsolv and the generic ingredients buprenorphine and naloxone. It includes dosage form details, quantity of 30 sublingual tablets (10 tablets x 3 cards), manufacturer Orexo US, Inc., and important usage instructions and warnings.*

FDA Label Image

Principal Display Panelndc 54123-986-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets8.6 mg/2.1 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reach Of Children. Buprenorphine Can Cause Severe, Possibly Fatal, Respiratory Depression In Children. Children Who Accidentally Take Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guide For Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 0b)

Zubsolv 2.9 mg/0.71 mg sublingual tablets packaging label shows the product name with active ingredients buprenorphine and naloxone. The tablets are menthol flavored and presented in a package containing 30 tablets (10 tablets x 3 cards). The label includes usage instructions, safety warnings, the lot and expiration placeholders, and is manufactured by Orexo US, Inc. It is a prescription drug for sublingual administration.*

FDA Label Image

Principal Display Panelndc 54123-114-30rx Only Ciiizubsolv® (buprenorphine And Naloxone) Sublingual Tablets11.4 mg/2.9 mg Menthol Flavorfor Sublingual Administration.do Not Cut, Crush, Break, Chew, Or Swallow Tablet. Keep Zubsolv In A Safe Place, Out Of The Sight And Reach Of Children. Buprenorphine Can Cause Severe, Possibly Fatal, Respiratory Depression In Children. Children Who Accidentally Take Zubsolv Will Require Immediate Medical Attention. Read Enclosed Zubsolv Medication Guide For Important Safety Information.30 Sublingual Tablets (10 Tablets X3 Cards)www.zubsolv.com (Zubsolv Sublingual Tablets 0c)

Zubsolv sublingual tablets packaging label for 5.7 mg / 1.4 mg strength of buprenorphine hydrochloride and naloxone hydrochloride. The label shows a box containing 30 orally disintegrating tablets in menthol flavor. The labeler is Orexo US, Inc. Instructions for use, safety warnings, and lot/expiration details are included.*

FDA Label Image

Zubsolv Sublingual Tablets 0d

Zubsolv 8.6 mg / 2.1 mg sublingual tablets packaging label for buprenorphine and naloxone. The label is menthol flavored and contains 30 sublingual tablets (10 tablets x 3 cards). It includes instructions for storage, warnings, and directions for use. Manufactured by Orexo US, Inc.*

FDA Label Image

Zubsolv Sublingual Tablets 0e

Packaging label for Zubsolv 11.4 mg / 2.9 mg sublingual tablets. The label shows the product name, active ingredients buprenorphine and naloxone, strength, dosage form as sublingual tablets, and menthol flavor. It includes instructions, safety warnings, lot and expiration details, barcode, and is labeled for prescription use by Orexo US, Inc. The package contains 30 sublingual tablets (10 tablets x 3 cards).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.